William Blair & Company’s Invesco Pharmaceuticals ETF PJP Stock Holding History

William Blair & Company’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.23K	Hold	60	–	–	﹤0.01%	1860
2025 Q4	$6.27K	Hold	60	–	–	﹤0.01%	1801
2025 Q3	$5.55K	Hold	60	–	–	﹤0.01%	1787
2025 Q2	$4.79K	Hold	60	–	–	﹤0.01%	1767
2025 Q1	$5.2K	Hold	60	–	–	﹤0.01%	1745
2024 Q4	$4.96K	Hold	60	–	–	﹤0.01%	1766
2024 Q3	$5.22K	Hold	60	–	–	﹤0.01%	1781
2024 Q2	$4.93K	Buy	+60	New	+$4.77K	﹤0.01%	1779
2022 Q3	–	Sell	-28	Closed	-$2K	–	1872
2022 Q2	$2K	Hold	28	–	–	﹤0.01%	1842
2022 Q1	$2K	Hold	28	–	–	﹤0.01%	1892
2021 Q4	$2K	Hold	28	–	–	﹤0.01%	1945
2021 Q3	$2K	Hold	28	–	–	﹤0.01%	1856
2021 Q2	$2K	Hold	28	–	–	﹤0.01%	1866
2021 Q1	$2K	Hold	28	–	–	﹤0.01%	1837
2020 Q4	$2K	Hold	28	–	–	﹤0.01%	1797
2020 Q3	$2K	Hold	28	–	–	﹤0.01%	1693
2020 Q2	$2K	Hold	28	–	–	﹤0.01%	1651
2020 Q1	$2K	Buy	+28	New	+$1.71K	﹤0.01%	1627

Other funds holding PJP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

William Blair & Company's PJP Position: Q1 2026 in Review

William Blair & Company held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2026 at 60 shares worth $6.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1860.

William Blair & Company first reported a position in PJP in Q1 2020 and has held it in 18 quarters since. The position peaked at $6.27K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

William Blair & Company held 60 shares of Invesco Pharmaceuticals ETF worth $6.23K as of Q1 2026.
William Blair & Company left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1860 holding.
William Blair & Company first reported a position in Invesco Pharmaceuticals ETF in Q1 2020 and has held it in 18 quarters since.
William Blair & Company's Invesco Pharmaceuticals ETF position peaked at $6.27K in Q4 2025.
119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.